Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 03/10: (VCEL) (XOMA) (BOX) Higher; (EXXI) (OME) (JAX) Lower (more...)

March 10, 2016 9:30 AM
Vericel (NASDAQ: VCEL) 71% HIGHER; announced top-line results from the company’s Phase 2b ixCELL-DCM clinical trial of ixmyelocel-T in patients ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles